| 000 | 01466 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515062613.0 | ||
| 264 | 0 | _c20070730 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0008-4182 | ||
| 024 | 7 |
_a10.3129/can j ophthalmol.i07-026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKumar, Atul | |
| 245 | 0 | 0 |
_aRapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab. _h[electronic resource] |
| 260 |
_bCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _cApr 2007 |
||
| 300 |
_a335-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOptic Disk _xblood supply |
| 650 | 0 | 4 |
_aRetinal Neovascularization _xdrug therapy |
| 650 | 0 | 4 |
_aRetinal Vasculitis _xcomplications |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aVitreous Body |
| 700 | 1 | _aSinha, Subijay | |
| 773 | 0 |
_tCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _gvol. 42 _gno. 2 _gp. 335-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3129/can j ophthalmol.i07-026 _zAvailable from publisher's website |
| 999 |
_c16946831 _d16946831 |
||